Unknown

Dataset Information

Stereotactic radiotherapy of nodal oligometastases from prostate cancer: a prisma-compliant systematic review.


ABSTRACT: Androgen deprivation therapy (ADT) is the standard treatment of metastatic prostate cancer (PCa). However, metastases-directed therapies can delay the initiation or switch of systemic treatments and allow local control (LC) and prolonged progression-free survival (PFS), particularly in patients with lymph nodes (LN) oligometastases. We performed a systematic review on stereotactic body radiotherapy (SBRT) in this setting. Papers reporting LC and/or PFS were selected. Data on ADT-free survival, overall survival, and toxicity were also collected from the selected studies. Fifteen studies were eligible (414 patients), 14 of them were retrospective analyses. A high heterogeneity was observed in terms of patient selection and treatment. In one study SBRT was delivered as a single 20 Gy fraction

SUBMITTER: Zamagni A 

PROVIDER: S-EPMC9637632 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature